GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Total Liabilities

Cangene (FRA:YGE) Total Liabilities : €68.27 Mil (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Total Liabilities?

Cangene's Total Liabilities for the quarter that ended in Oct. 2013 was €68.27 Mil.

Cangene's quarterly Total Liabilities declined from Apr. 2013 (€71.07 Mil) to Jul. 2013 (€68.46 Mil) and declined from Jul. 2013 (€68.46 Mil) to Oct. 2013 (€68.27 Mil).

Cangene's annual Total Liabilities declined from Jul. 2011 (€30.07 Mil) to Jul. 2012 (€29.81 Mil) but then increased from Jul. 2012 (€29.81 Mil) to Jul. 2013 (€68.46 Mil).


Cangene Total Liabilities Historical Data

The historical data trend for Cangene's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Total Liabilities Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.28 39.21 30.07 29.81 68.46

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.58 32.84 71.07 68.46 68.27

Cangene Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cangene's Total Liabilities for the fiscal year that ended in Jul. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=24.132+(0+38.524
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+5.806+0)
=68.46

Total Liabilities=Total Assets (A: Jul. 2013 )-Total Equity (A: Jul. 2013 )
=218.9-150.438
=68.46

Cangene's Total Liabilities for the quarter that ended in Oct. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26.065+(0+37.33
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+4.874+0)
=68.27

Total Liabilities=Total Assets (Q: Oct. 2013 )-Total Equity (Q: Oct. 2013 )
=208.847-140.578
=68.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cangene's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines